KZIA - Banter and General Comments, page-112

It was actually worse than SOC for the recurrents which was a larger group.

It may work for DIPG in the right combination but GBM is over this test shows why the CEO, Chair and secretary quit as soon as poosible after not progressing to the next stage.

This may be a milk the market for some cash to buy another year of wages in an unlikley FDA attempt.
This is a great thing for those with a money allergy though.

Good luck.